UnknownNCT01676077
Clinical Outcome Study for Dysferlinopathy
Studying Qualitative or quantitative defects of dysferlin
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Principal Investigator
- Volker StraubNewcastle University
- Enrollment
- 200 enrolled
- Eligibility
- 10 years · All sexes
- Timeline
- 2012 – 2024
Study locations (16)
- UC Irvine, Orange, California, United States
- Stanford University Medical Center, Palo Alto, California, United States
- Neurology & Pathology, Washington University, School of Medicine in St Louis, St Louis, Missouri, United States
- Columbia University Medical Centre, New York, New York, United States
- Carolinas Medical Center, Neuroscience & Spine Institute, Dept of Neurology, Charlotte, North Carolina, United States
- Neuromuscular Center at the Research Institute of Nationwide Children's Hospital, Columbus, Ohio, United States
- Clinica Davila, Santiago, Chile
- Rigshospitalet Neuromusculaer Klinik, Copenhagen, Denmark
- Institut de Myologie, Paris, France
- Department of Neurosciences, University of Padova, Padua, Italy
- National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
- Pusan National University Hospital, Busan, South Korea
- Hospital Sant Pau, Neurology Department, Barcelona, Spain
- Hospital Universitario Donostia, San Sebastián, Spain
- Hospital Universitario Virgen del Rocio, IBiS, Neurology Department, Seville, Spain
- +1 more locations on ClinicalTrials.gov
Collaborators
Jain Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01676077 on ClinicalTrials.gov